NGL Fine-Chem cash flow

Latest FY26

Cash from operations: ₹43.3cr+20.9% on FY25
Capital spending: ₹89.9cr−31.3% on FY25
Free cash flow: −₹46.5cr−₹94.9 cr in FY25
Cash from financing: ₹29.5cr−₹1.1 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Adjustments to reconcile profit — non-cash items
	—	19.6	12.5	11.6	11.3
	—	4.5	2.3	0.0	1.2
	—	−0.7	−0.6	0.0	0.0
	—	−0.0	−0.2	0.0	0.0
	—	−0.2	−0.2	−0.2	−0.1
	—	2.7	0.0	0.0	0.0
Changes in working capital
	—	−19.0	−8.0	−16.3	29.0
	—	−48.0	8.1	−23.7	0.0
	—	0.0	0.0	0.0	−1.9
	—	3.9	−12.3	−11.4	−12.5
	—	0.0	7.8	−0.1	−1.8
	—	2.4	−10.4	−6.0	3.4
	—	1.1	−1.7	−1.5	−0.2
	—	12.5	8.1	24.8	−12.6
	—	17.4	8.2	0.3	−0.8
	—	1.5	0.0	1.3	0.0
	—	−2.4	−0.7	−0.2	0.9
	—	−0.8	0.3	0.9	−0.6
	—	0.1	0.7	0.1	0.1
	—	0.7	0.8	0.5	0.2
Cash from operating activities
	75.9	63.4	27.7	54.4	27.4
	—	−4.8	14.7	−19.8	15.7
	—	58.6	42.4	34.6	43.0
	—	0.0	0.0	−0.6	0.0
	—	0.0	0.0	0.0	0.2
	—	0.0	0.0	−0.5	−0.6
	—	15.2	6.6	13.1	6.9
	—	43.3	35.8	20.5	35.3
Cash from investing activities
	—	89.9	131	28.5	31.4
	—	3.8	57.0	0.0	1.1
	—	20.5	0.0	0.0	0.0
	—	−2.7	0.0	0.0	0.0
	—	0.0	0.2	0.5	0.6
	—	0.7	0.6	0.6	0.2
	—	−3.0	38.4	0.6	2.4
	—	−70.6	−34.6	−26.8	−27.0
Cash from financing activities
	—	35.1	0.0	0.0	0.0
	—	4.5	0.0	0.0	0.0
	—	1.1	1.1	1.1	1.1
	—	0.0	0.0	−0.0	0.0
	—	29.5	−1.1	−1.1	−1.1
	—	2.3	0.2	−7.4	7.2
	—	2.3	0.2	−7.4	7.2
	—	—	—	0.4	7.8
Reference items
	84.2	72.7	33.9	53.3	34.3
	15.7%	14.5%	9.2%	15.7%	12.3%
	−46.5	−46.5	−94.9	−8.1	3.9
	—	−15.7	—	—	—
	−₹75.32	−₹75.32	−₹153.69	−₹13.04	₹6.28
	—	0.90×	1.70×	0.50×	1.72×
	—	15.2	6.6	13.1	6.9
	—	4.5	—	—	0.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NGLFINE₹2,610.60

NGL Fine-Chem Limited

· Pharma & Health

₹ CrorePeersSYNCOMF JAGSNPHARM HESTERBIOAMRUTANJAN WINDLAS INDOCO SAIPARENTMcap ₹1,613 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	11.3	11.6	12.5	19.6	—
+ Finance Costs	1.2	0.0	2.3	4.5	—
+ Interest Income	0.0	0.0	-0.6	-0.7	—
+ Dividend Income	0.0	0.0	-0.2	-0.0	—
+ Other Non-cash Items	-0.1	-0.2	-0.2	-0.2	—
+ Other Reconciling Items	0.0	0.0	0.0	2.7	—
Changes in Working Capital
+ Inventories	29.0	-16.3	-8.0	-19.0	—
+ Trade Receivables — Current	0.0	-23.7	8.1	-48.0	—
+ Trade Receivables — Non-current	-1.9	0.0	0.0	0.0	—
+ Other Financial Assets — Current	-12.5	-11.4	-12.3	3.9	—
+ Other Financial Assets — Non-current	-1.8	-0.1	7.8	0.0	—
+ Other Current Assets	3.4	-6.0	-10.4	2.4	—
+ Other Non-current Assets	-0.2	-1.5	-1.7	1.1	—
+ Trade Payables — Current	-12.6	24.8	8.1	12.5	—
+ Other Financial Liabilities — Current	-0.8	0.3	8.2	17.4	—
+ Other Financial Liabilities — Non-current	0.0	1.3	0.0	1.5	—
+ Other Current Liabilities	0.9	-0.2	-0.7	-2.4	—
+ Other Non-current Liabilities	-0.6	0.9	0.3	-0.8	—
+ Provisions — Current	0.1	0.1	0.7	0.1	—
+ Provisions — Non-current	0.2	0.5	0.8	0.7	—
Cash from Operating Activities
Profit Before Tax (per I/S)	27.4	54.4	27.7	63.4	75.9
+ Total Adjustments (incl. Working Capital)	15.7	-19.8	14.7	-4.8	—
Cash from Operations (pre-tax)	43.0	34.6	42.4	58.6	—
+ Interest Received — Operating	0.0	-0.6	0.0	0.0	—
+ Interest Paid — Operating	0.2	0.0	0.0	0.0	—
+ Dividends Received — Operating	-0.6	-0.5	0.0	0.0	—
+ Income Taxes Paid	6.9	13.1	6.6	15.2	—
Cash from Operating Activities	35.3	20.5	35.8	43.3	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	31.4	28.5	130.8	89.9	—
+ Disp of Fixed Assets	1.1	0.0	57.0	3.8	—
+ Disp of Investment Property	0.0	0.0	0.0	20.5	—
+ Receipts on Futures / Forwards / Options / Swaps	0.0	0.0	0.0	-2.7	—
+ Dividends Received — Investing	0.6	0.5	0.2	0.0	—
+ Interest Received — Investing	0.2	0.6	0.6	0.7	—
+ Other Inflows / (Outflows) — Investing	2.4	0.6	38.4	-3.0	—
Cash from Investing Activities	-27.0	-26.8	-34.6	-70.6	—
Cash from Financing Activities
+ Proceeds from Borrowings	0.0	0.0	0.0	35.1	—
+ Interest Paid	0.0	0.0	0.0	4.5	—
+ Dividends Paid	1.1	1.1	1.1	1.1	—
+ Other Inflows / (Outflows) — Financing	0.0	-0.0	0.0	0.0	—
Cash from Financing Activities	-1.1	-1.1	-1.1	29.5	—
Net Changes in Cash (pre-FX)	7.2	-7.4	0.2	2.3	—
Net Changes in Cash	7.2	-7.4	0.2	2.3	—
Closing Cash	7.8	0.4	—	—	—
Reference Items
EBITDA	34.3	53.3	33.9	72.7	84.2
EBITDA Margin %	12.34	15.73	9.20	14.51	15.70
Free Cash Flow (CFO − Capex)	3.9	-8.1	-94.9	-46.5	-46.5
Free Cash Flow to Equity	—	—	—	-15.7	—
Free Cash Flow per Basic Share	6.28	-13.04	-153.69	-75.32	-75.32
Cash Flow to Net Income	1.72	0.50	1.70	0.90	—
Cash Paid for Taxes	6.9	13.1	6.6	15.2	—
Cash Paid for Interest	0.2	—	—	4.5	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.